Borregaard ASA: EBITDA1 of NOK 510 million in the 2nd quarter

Borregaard ASA: EBITDA1 of NOK 510 million in the 2nd quarter

Issuer

Borregaard ASA

Borregaard's operating revenues were NOK 1,949 million (NOK 1,963 million)(2) in
the 2(nd) quarter of 2024. EBITDA(1) was NOK 510 million (NOK 537 million). The
result in BioSolutions increased while the result in BioMaterials was lower
compared with the 2(nd) quarter of 2023. Fine Chemicals delivered a strong
result slightly below the same quarter last year.

Improved product mix and reduced energy costs were the main reasons for a strong
result in BioSolutions. In BioMaterials, the result was affected by lower sales
prices, higher wood costs and an increase in other operating expenses, mainly
due to cost inflation. Fine Chemicals had a solid result in the quarter. High
deliveries and stable prices for bioethanol and a favourable product mix for
fine chemical intermediates contributed positively to the result. The net
currency effects were negative for the Group.

Profit before tax was NOK 322 million (NOK 379 million). Earnings per share were
NOK 2.45 (NOK 2.84).

- We are pleased with the strong performance in BioSolutions and a solid result
for the Group, says President and CEO Per A. Sørlie.

Contacts:
Director Investor Relations, Knut-Harald Bakke, +47 905 79 164
SVP Organisation and Public Affairs, Dag Arthur Aasbø, +47 918 34 108

1. Operating profit before depreciation, amortisation and other income and
expenses
2. Figures in parentheses are for the corresponding period in the preceding year

This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to Section 5 - 12 of the Norwegian Securities Trading Act.

This stock exchange announcement was published by Lotte Kvinlaug, Investor
Relations Officer at Borregaard ASA, on 17 July 2024 at 07:00 CEST.

More information:
Access the news on Oslo Bors NewsWeb site

623730_Quarterly and accounting figures 2nd quarter 2024.pdf
623730_2nd quarter 2024 report.pdf
623730_2nd quarter 2024 presentation.pdf